HDL-Raising Drugs: No Value in the Statin Era?HDL-Raising Drugs: No Value in the Statin Era?

In the era of widespread statin use, investigators say studies testing fibrates, niacin, and CETP inhibitors do not support raising HDL pharmacologically to reduce clinical outcomes. Heartwire
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology News Source Type: news

Related Links:

CONCLUSIONS: Statin therapy can cause a significant increase in hsTnT levels after moderate exercise. This increase can jeopardise the accuracy of clinical diagnoses based on the newly implemented algorithms. The awareness of these adverse effects of statins, mainly used by patients with high risk of coronary events, can prevent misdiagnosis or unnecessary hospitalisations. PMID: 30328783 [PubMed - as supplied by publisher]
Source: Acta Cardiologica - Category: Cardiology Tags: Acta Cardiol Source Type: research
Australia's competition watchdog said on Friday the High Court dismissed its special leave application to appeal a court's decision on whether Pfizer Inc's local unit used its market power to limit competition for its cholesterol-lowering drug Lipitor.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Australia's competition watchdog said on Friday the High Court dismissed its special leave application to appeal a court's decision on whether Pfizer Inc's local unit used its market power to limit competition for its cholesterol-lowering drug Lipitor.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Authors: Okopień B, Bułdak Ł, Bołdys A Abstract INTRODUCTION: The need to reduce residual cardiovascular risk led to the development of novel therapeutic strategies to improve patients' outcomes. The residual risk in people with atherogenic dyslipidemia, despite LDL reduction obtained mainly by statins, remains high. Fibrates in those patients lead to significant clinical improvements. Those include reduction in the progression of atherosclerosis, which translates into decrease in cardiovascular events and improvements in microvascular diabetic complications. Furthermore there are other clinical and biochemical...
Source: Expert Review of Clinical Pharmacology - Category: Drugs & Pharmacology Tags: Expert Rev Clin Pharmacol Source Type: research
Though heart is known primarily as a pump, it is the four cardiac valves that ensures the critical , non-stop unidirectional flow that sustain the circulation . It is to be recalled these valves originate in the very early days of cardiac development when the primitive heart tube loops , even as the chambers expand from primitive ventricle. Mesenchymal differentiation controlled by various genes that cleaves the valve from myocardial tissue. While heart by itself is the supreme vascular organ ,  its surprising  few structures inside the heart , like the valves are quiet avascular ( or is it really so ?)...
Source: Dr.S.Venkatesan MD - Category: Cardiology Authors: Tags: cardiac embryology Embryology : Heart valve development Infective endocarditis : Pathology valvular heart disease blood supply to heart valves hematogenous spread of infective endocarditis how bacteria reach mitral valve in infective endocardi Source Type: blogs
No abstract available
Source: Neurology Today - Category: Neurology Tags: NeuroTech Source Type: research
ConclusionsWe found substantial variation in statin medication adherence following diagnosis by cancer type and race/ethnicity among a large cohort of prevalent statin users in an integrated health care setting.Implications for Cancer SurvivorsImproving our understanding of comorbidity management and polypharmacy across diverse cancer patient populations is warranted to develop tailored interventions that improve medication adherence and reduce disparities in health outcomes.
Source: Journal of Cancer Survivorship - Category: Cancer & Oncology Source Type: research
Statin reduces the risk of dementia in diabetic patients receiving androgen deprivation therapy for prostate cancer, Published online: 18 October 2018; doi:10.1038/s41391-018-0091-4Statin reduces the risk of dementia in diabetic patients receiving androgen deprivation therapy for prostate cancer
Source: Prostate Cancer and Prostatic Diseases - Category: Urology & Nephrology Authors: Source Type: research
High-dose statin (HDS) therapy is recommended to reduce low-density lipoprotein cholesterol (LDL-C); however, some patients are unable to tolerate the associated side effects. Nutraceuticals have shown efficacy in lowering LDL-C. The aim of this study was to evaluate whether the combination of low-dose statin (LDS) plus ezetimibe (EZE) or LDS plus nutraceutical (Armolipid Plus [ALP] containing red yeast rice, policosanol, and berberine) can lead to a higher proportion of high-risk patients achieving target LDL-C.
Source: The American Journal of Cardiology - Category: Cardiology Authors: Source Type: research
Statin use in patients listed for in kidney transplant is thought to be beneficial. However, the optimum statin dose for improved survival in this high-risk population is unknown. Our study aimed to determine the impact of pre-kidney transplant statin dosage on survival post-kidney transplant. In this retrospective cohort study, we enrolled patients who underwent kidney transplant between January 2005 and September 2015 at Rush University Medical. Data on the statin use and intensity used prior to kidney transplant were obtained.
Source: The American Journal of Cardiology - Category: Cardiology Authors: Source Type: research
More News: Cardiology | Cholesterol | Heart | Niacin | Niaspan | Statin Therapy | Study